You can buy or sell Regeneron and other stocks, options, ETFs, and crypto commission-free!
Regeneron Pharmaceuticals, Inc. Common Stock, also called Regeneron, is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Read More It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.
Tarrytown, New York
52 Week High
52 Week Low
Stocks making the biggest moves midday: Johnson & Johnson, Eldorado Resorts, Regeneron & more
Check out the companies making headlines midday Monday: Johnson & Johnson — Johnson & Johnson shares jumped more than 7% after the company announced it has a c
Regeneron Announces American College of Cardiology Presentation of Positive Phase 3 Evinacumab Results in Patients with Severe Inherited Form of High Cholesterol
TARRYTOWN, N.Y., March 30, 2020 /PRNewswire/ -- Results from separate positive Phase 3 trial of Praluent® (alirocumab) in patients with HoFH also presented; FD
— per share
Expected May 5, Pre-Market
Developing a vaccine takes 10 years. Sanofi seeks to do so within 18 months
The process to develop a vaccine typically takes a decade, but an untypical circumstance is calling for it to be done in a fraction of the time, the head of a F